Topic：How the Pandemic and Other Recent Developments Have Impacted the Business Environment - from Supply Chain to Customers? A Business Insights & Analytics View
Speaker：Robin Niethammer, Bayer Pharma
Time：July 12, 2022 (Tuesday) 15:00—16:00
Virtual Platform：Tencent ID：558-3314-9190
Organizers：School of Business Administration, Office of International Exchange and Cooperation, Research Office
Speaker’s Profile:
Robin Niethammer is a financial management, controlling and HR content matter expert with more than 20 years of experience, including work with multinational corporations such as Bayer, Siemens, and Nokia.
In his current role as global Separation Lead for Bayer Pharma, Robin is responsible for the successful separation of non-core assets to acquirers starting already before a due diligence. In his previous role as Director Business Insights & Analytics he observed and analyzed the changes in the competitive environment in the pharmaceutical business.
Robin spent 3 years in Chengdu, China, where he was the Head of CAO Region West China (CFO) for Bayer HealthCare covering 18 Chinese provinces. While in China, he served as Chairman and board member of the European Chamber of Commerce Southwest China. His leadership contributed significantly to the Chamber’s first published Regional Position Paper which - covered extensively by the media - was well received by the business community and the local government.
Robin attended Technical University (TU) Dresden in Germany from which he obtained a graduate degree in business management. He also studied in Belgium and Switzerland.
Lecture Preview：
Due to the pandemic and other recent developments one can observe changes in customer behavior, uncertainties in product supply, new forms of business interaction. These are all challenges yet also opportunities to analyze business practices and renew or adjust processes. Certain innovations needed more time due to the Covid situation while other innovations, especially in the digital arena got a boost. The presentation will explain in general the above topics and will focus in particular on the pharmaceutical industry.
